These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11730832)

  • 21. Elevated levels of total homocysteine after ischemic stroke: a potential marker for in-hospital outcomes.
    Liu W; Ma XL; Gu HQ; Li H; Li ZX; Wang YJ
    Neurol Res; 2023 Jun; 45(6):497-504. PubMed ID: 36893016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between homocysteine and mortality in chronic kidney disease.
    Menon V; Sarnak MJ; Greene T; Wang X; Pereira AA; Beck GJ; Kusek JW; Selhub J; Collins AJ; Levey AS; Shlipak MG
    Circulation; 2006 Mar; 113(12):1572-7. PubMed ID: 16549639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
    Youssef MY; Mojiminiyi OA; Abdella NA
    Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
    Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine and diabetes: Role in macrovascular and microvascular complications.
    Muzurović E; Kraljević I; Solak M; Dragnić S; Mikhailidis DP
    J Diabetes Complications; 2021 Mar; 35(3):107834. PubMed ID: 33419630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.
    Hoogeveen EK; Kostense PJ; Beks PJ; Mackaay AJ; Jakobs C; Bouter LM; Heine RJ; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):133-8. PubMed ID: 9445267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma total homocysteine in Brazilian overweight and non-overweight adolescents: a case-control study.
    Brasileiro RS; Escrivão MA; Taddei JA; D'Almeida V; Ancona-Lopez F; Carvalhaes JT
    Nutr Hosp; 2005; 20(5):313-9. PubMed ID: 16229398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study.
    de Bree A; Verschuren WM; Blom HJ; Nadeau M; Trijbels FJ; Kromhout D
    Atherosclerosis; 2003 Feb; 166(2):369-77. PubMed ID: 12535751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.
    Christ-Crain M; Meier C; Guglielmetti M; Huber PR; Riesen W; Staub JJ; Müller B
    Atherosclerosis; 2003 Feb; 166(2):379-86. PubMed ID: 12535752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
    Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
    J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in lifestyle, biological risk factors and total homocysteine in relation to MTHFR C677T genotype: a 5-year follow-up study.
    Husemoen LL; Linneberg A; Fenger M; Thuesen BH; Jørgensen T
    Eur J Clin Nutr; 2009 Oct; 63(10):1233-40. PubMed ID: 19654594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases.
    Ebesunun MO; Obajobi EO
    Pan Afr Med J; 2012; 12():48. PubMed ID: 22937188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia.
    Ravaglia G; Forti P; Maioli F; Servadei L; Martelli M; Arnone G; Talerico T; Zoli M; Mariani E
    Exp Gerontol; 2004 Mar; 39(3):443-50. PubMed ID: 15036404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.